Jazz Pharmaceuticals (JAZZ) Research & Development (2010 - 2026)
Jazz Pharmaceuticals' quarterly Research & Development came in at $196.0 million in Q1 2026, up 8.47% year-on-year from $180.7 million in Q1 2025, and down 8.37% quarter-over-quarter from $213.9 million in Q4 2025.
Jazz Pharmaceuticals has reported Research & Development for 17 years, with the latest figure at $196.0 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development rose 8.47% year-over-year to $196.0 million; the trailing twelve-month figure through Mar 2026 stood at $798.1 million (down 5.2% YoY), and the FY2025 full-year result was $782.7 million, down 11.46% from the prior year.
- Research & Development for Q1 2026 stood at $196.0 million, down from $213.9 million in the prior quarter.
- The five-year high for Research & Development was $240.5 million in Q4 2024, with the low at $130.0 million in Q1 2022.
- Average Research & Development over 5 years is $194.3 million, with a median of $198.2 million recorded in 2025.
- Year-over-year, Research & Development surged 69.75% in 2022 and slipped 18.91% in 2025.
- Tracing JAZZ's Research & Development over 5 years: stood at $172.6 million in 2022, then increased by 25.53% to $216.6 million in 2023, then climbed by 11.03% to $240.5 million in 2024, then retreated by 11.06% to $213.9 million in 2025, then retreated by 8.37% to $196.0 million in 2026.
- The last three Research & Development figures came in at $196.0 million (Q1 2026), $213.9 million (Q4 2025), and $198.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 626,092.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 4.32 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -101.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 1.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 961.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -2.30 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.54 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 364.87 Mn |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn | 196.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 196.00 Mn |
| Dec 31, 2025 | 213.91 Mn |
| Sep 30, 2025 | 198.20 Mn |
| Jun 30, 2025 | 189.97 Mn |
| Mar 31, 2025 | 180.70 Mn |
| Dec 31, 2024 | 240.50 Mn |
| Sep 30, 2024 | 199.92 Mn |
| Jun 30, 2024 | 220.73 Mn |
| Mar 31, 2024 | 222.85 Mn |
| Dec 31, 2023 | 216.61 Mn |
| Sep 30, 2023 | 234.40 Mn |
| Jun 30, 2023 | 209.24 Mn |
| Mar 31, 2023 | 189.41 Mn |
| Dec 31, 2022 | 172.56 Mn |
| Sep 30, 2022 | 148.87 Mn |
| Jun 30, 2022 | 139.05 Mn |
| Mar 31, 2022 | 129.98 Mn |
| Dec 31, 2021 | 155.44 Mn |
| Sep 30, 2021 | 141.04 Mn |
| Jun 30, 2021 | 132.70 Mn |
| Mar 31, 2021 | 76.57 Mn |
| Dec 31, 2020 | 91.70 Mn |
| Sep 30, 2020 | 78.65 Mn |
| Jun 30, 2020 | 78.92 Mn |
| Mar 31, 2020 | 86.11 Mn |
| Dec 31, 2019 | 97.38 Mn |
| Sep 30, 2019 | 79.86 Mn |
| Jun 30, 2019 | 62.38 Mn |
| Mar 31, 2019 | 60.11 Mn |
| Dec 31, 2018 | 56.66 Mn |
| Sep 30, 2018 | 51.16 Mn |
| Jun 30, 2018 | 56.13 Mn |
| Mar 31, 2018 | 62.67 Mn |
| Dec 31, 2017 | 26.50 Mn |
| Sep 30, 2017 | 47.36 Mn |
| Jun 30, 2017 | 40.16 Mn |
| Mar 31, 2017 | 44.93 Mn |
| Dec 31, 2016 | 44.16 Mn |
| Sep 30, 2016 | 15.00 Mn |
| Jun 30, 2016 | 39.09 Mn |
| Mar 31, 2016 | 8.80 Mn |
| Dec 31, 2015 | 29.46 Mn |
| Sep 30, 2015 | 25.00 Mn |
| Jun 30, 2015 | 27.83 Mn |
| Mar 31, 2015 | 27.18 Mn |
| Dec 31, 2014 | 24.56 Mn |
| Sep 30, 2014 | 22.42 Mn |
| Jun 30, 2014 | 20.09 Mn |
| Mar 31, 2014 | 18.11 Mn |
| Sep 30, 2013 | 11.83 Mn |
| Jun 30, 2013 | 9.25 Mn |
| Mar 31, 2013 | 6.75 Mn |
| Dec 31, 2012 | 7.28 Mn |
| Sep 30, 2012 | 6.92 Mn |
| Jun 30, 2012 | 2.32 Mn |
| Mar 31, 2012 | 3.96 Mn |
| Dec 31, 2011 | 3.76 Mn |
| Sep 30, 2011 | 3.28 Mn |
| Jun 30, 2011 | 3.38 Mn |
| Mar 31, 2011 | 3.70 Mn |
| Dec 31, 2010 | 4.12 Mn |
| Sep 30, 2010 | 7.32 Mn |
| Jun 30, 2010 | 7.96 Mn |